Top 230 medical and healthcare startups in New York
May 11, 2026
|
Like
23
1
Funding: $29.9M
Dandelion Health AI develops a clinical data and artificial intelligence platform that enables researchers to analyze patient data.
Dandelion Health AI develops a clinical data and artificial intelligence platform that enables researchers to analyze patient data.
2
Funding: $20M
Blossom Health is a telehealth platform that specializes in psychiatry, aiming to provide access to mental health services.
Blossom Health is a telehealth platform that specializes in psychiatry, aiming to provide access to mental health services.
3
Funding: $180M
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
4
Funding: $93.9M
Adonis is a revenue intelligence and automation platform built for healthcare that improve critical RCM outcomes.
Adonis is a revenue intelligence and automation platform built for healthcare that improve critical RCM outcomes.
5
Funding: $60M
Thesis offers AI agents within healthcare to assist with clinical operations and care management.
Thesis offers AI agents within healthcare to assist with clinical operations and care management.
6
Funding: $1.1B
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
7
Funding: $312.1M
Eight Sleep is a sleep fitness company that leverages personal biometrics to restore individuals to their peak energy levels each morning.
Eight Sleep is a sleep fitness company that leverages personal biometrics to restore individuals to their peak energy levels each morning.
8
Funding: $28.6M
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
9
Funding: $328M
Grow Therapy helps therapists easily start and grow thriving insurance-accepting practices, giving them the administrative and business tools, peer community support, and pipeline of referrals they need to make their lives better.
Grow Therapy helps therapists easily start and grow thriving insurance-accepting practices, giving them the administrative and business tools, peer community support, and pipeline of referrals they need to make their lives better.
10
Funding: $219.3M
Garner Health is a provider of healthcare services used to help employers give their employees a better healthcare experience.
Garner Health is a provider of healthcare services used to help employers give their employees a better healthcare experience.
11
Funding: $41.7M
DocDelta helps companies in the healthcare ecosystem find and connect with the healthcare institutions and contacts that are most important to them. Marketing, recruiting and sales teams at healthcare services, medical technology companies, hospitals and medical groups trust DocDelta to help them identify and close new business opportunities with personalized conversations at the right time.
DocDelta helps companies in the healthcare ecosystem find and connect with the healthcare institutions and contacts that are most important to them. Marketing, recruiting and sales teams at healthcare services, medical technology companies, hospitals and medical groups trust DocDelta to help them identify and close new business opportunities with personalized conversations at the right time.
12
Funding: $15.2M
BioVaxys develops immunotherapeutic cancer vaccines targeting lymphoma and ovarian cancer. The company develops them using its proprietary DPX delivery platform. Unlike conventional emulsions or lipid nanoparticles that release their contents systemically, DPX is fully synthetic and compatible with peptides, proteins, mRNA, virus-like particles and small molecules. It is ideal for mRNA delivery, remaining localized at the injection site with superior stability compared to LDL. Maveropepimute-S, the company's lead clinical drug based on this platform, demonstrated an overall response rate of 21% and a disease control rate of 63% in recurrent ovarian cancer. In relapsed/refractory DLBL, the combination of MVP-S and Keytruda achieved complete remission in 3 of 6 evaluable patients. This means that no detectable cancer cells remained after treatment.
BioVaxys develops immunotherapeutic cancer vaccines targeting lymphoma and ovarian cancer. The company develops them using its proprietary DPX delivery platform. Unlike conventional emulsions or lipid nanoparticles that release their contents systemically, DPX is fully synthetic and compatible with peptides, proteins, mRNA, virus-like particles and small molecules. It is ideal for mRNA delivery, remaining localized at the injection site with superior stability compared to LDL. Maveropepimute-S, the company's lead clinical drug based on this platform, demonstrated an overall response rate of 21% and a disease control rate of 63% in recurrent ovarian cancer. In relapsed/refractory DLBL, the combination of MVP-S and Keytruda achieved complete remission in 3 of 6 evaluable patients. This means that no detectable cancer cells remained after treatment.
13
Funding: $2.5B
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. It is a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.
Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. It is a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.
14
Funding: $2B
Oscar is a health insurance company that employs technology, design, and data to humanize health care.
Oscar is a health insurance company that employs technology, design, and data to humanize health care.
15
Funding: $1.6B
IOVANCE Biotherapeutics develops personalized autologous cellular immunotherapies using tumor-infiltrating lymphocytes (TILs). A patient's natural TILs are collected and grown outside the body and then administered to the patient in a single dose. Unlike targeted cell therapies, which act on general antigen targets, IOVANCE TILs are engineered to act on specific neoantigens unique to the patient or tumor. IOVANCE's T-cell-based immunotherapy platform has potential application across multiple solid tumor types. The company has two approved drugs for the treatment of metastatic melanoma and metastatic kidney cancer. The company is also conducting clinical trials for the treatment of cervical cancer, NSCLC, endometrial cancer, and head and neck squamous cell carcinoma.
IOVANCE Biotherapeutics develops personalized autologous cellular immunotherapies using tumor-infiltrating lymphocytes (TILs). A patient's natural TILs are collected and grown outside the body and then administered to the patient in a single dose. Unlike targeted cell therapies, which act on general antigen targets, IOVANCE TILs are engineered to act on specific neoantigens unique to the patient or tumor. IOVANCE's T-cell-based immunotherapy platform has potential application across multiple solid tumor types. The company has two approved drugs for the treatment of metastatic melanoma and metastatic kidney cancer. The company is also conducting clinical trials for the treatment of cervical cancer, NSCLC, endometrial cancer, and head and neck squamous cell carcinoma.
16
Funding: $1B
Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
Ro is a telehealth startup that operates digital health clinics for men’s and women’s health, along with smoking cessation.
17
Funding: $896.6M
Zentalis is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics.
Zentalis is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics.
18
Funding: $891.3M
Cityblock is addressing the root causes of health for underserved urban populations.
Cityblock is addressing the root causes of health for underserved urban populations.
19
Funding: $736M
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
Capital Rx is a healthtech platform that provides pharmacy benefit management solutions.
20
Funding: $708M
LetsGetChecked offers a health test kit service so that you can take various common laboratory tests from the comfort of your home
LetsGetChecked offers a health test kit service so that you can take various common laboratory tests from the comfort of your home
21
Funding: $658.9M
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
Noom's fully-mobile programs prevent/manage/reverse chronic and pre-chronic conditions such as obesity, diabetes and hypertension.
22
Funding: $625.9M
Zocdoc is a technology company that provides better healthcare experience for millions of patients every month. It allows to book local doctors who take your insurance
Zocdoc is a technology company that provides better healthcare experience for millions of patients every month. It allows to book local doctors who take your insurance
23
Funding: $570M
Capsule is a healthcare technology business rebuilding the pharmacy from the inside out
Capsule is a healthcare technology business rebuilding the pharmacy from the inside out
24
Funding: $528M
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
25
Funding: $528M
Formation Bio is a biotech company using AI to speed up drug development, aiming for efficient patient treatment.
Formation Bio is a biotech company using AI to speed up drug development, aiming for efficient patient treatment.
26
Funding: $505M
Our purpose is to reduce the physical, emotional and economic burdens of obesity as a driver of diseases, creating value for the people we serve and the investors we work for.
Our purpose is to reduce the physical, emotional and economic burdens of obesity as a driver of diseases, creating value for the people we serve and the investors we work for.
27
Funding: $493.5M
SWORD Health is a medical company that created the first AI-powered digital physical therapist, shifting healthcare from analog to digital.
SWORD Health is a medical company that created the first AI-powered digital physical therapist, shifting healthcare from analog to digital.
28
Funding: $487.2M
At Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis—the communication highway between our gut and our brain—offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology.
At Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis—the communication highway between our gut and our brain—offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology.
29
Funding: $466.5M
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
Spring uses AI to help patients with mental health problems feel better faster. The startup operates as an online mental health clinic for employers, using proprietary machine-learning technology to provide personalized treatment recommendations with hopes that they will be more effective.
30
Funding: $452M
Talkiatry is a virtual mental health care platform with over 800 full-time psychiatrists. These specialists provide care for a variety of conditions, including anxiety, depression, insomnia, mood disorders, postpartum depression, pediatric mental health, bipolar disorder, OCD, PTSD and substance use disorders. Their work is powered by AI platform that facilitates interaction with patients between visits and monitors the quality and level of care provided. The startup also implements innovative payment models with insurance companies.
Talkiatry is a virtual mental health care platform with over 800 full-time psychiatrists. These specialists provide care for a variety of conditions, including anxiety, depression, insomnia, mood disorders, postpartum depression, pediatric mental health, bipolar disorder, OCD, PTSD and substance use disorders. Their work is powered by AI platform that facilitates interaction with patients between visits and monitors the quality and level of care provided. The startup also implements innovative payment models with insurance companies.
31
Funding: $447M
Pathos is a biotechnology company that leverages AI to accelerate solid tumor drug development.
Pathos is a biotechnology company that leverages AI to accelerate solid tumor drug development.
32
Funding: $419.4M
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevates the patient experience.
33
Funding: $418.7M
K Health has built the first HIPAA compliant AI health app 100% fueled by data, empowering users worldwide to take control of their health. By working with a unique data set of over a billion health interactions, K Health is able to generate better and more accurate insights based on PLM (a.k.a. “People Like Me”), a new approach to understanding our health that looks at other people like us who have had similar experiences.
K Health has built the first HIPAA compliant AI health app 100% fueled by data, empowering users worldwide to take control of their health. By working with a unique data set of over a billion health interactions, K Health is able to generate better and more accurate insights based on PLM (a.k.a. “People Like Me”), a new approach to understanding our health that looks at other people like us who have had similar experiences.
34
Funding: $417.1M
Maven Clinic is a virtual clinic dedicated for women and family health. It assists mothers and families during conception, throughout pregnancy, and postpartum.
Maven Clinic is a virtual clinic dedicated for women and family health. It assists mothers and families during conception, throughout pregnancy, and postpartum.
35
Funding: $413.7M
Talkspace is an online therapy startup that offers affordable and confidential therapy with network of professional and licensed therapists.
Talkspace is an online therapy startup that offers affordable and confidential therapy with network of professional and licensed therapists.
36
Funding: $407.2M
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
37
Funding: $386.5M
Cleerly is a digital healthcare company that provides diagnostic solutions for people with heart disease.
Cleerly is a digital healthcare company that provides diagnostic solutions for people with heart disease.
38
Funding: $383.5M
Neurogene develops gene therapies for inherited neurological diseases, initially focusing on a form of Batten disease.
Neurogene develops gene therapies for inherited neurological diseases, initially focusing on a form of Batten disease.
39
Funding: $360M
LEXEO Therapeutics develops gene therapy for the world's most devastating diseases
LEXEO Therapeutics develops gene therapy for the world's most devastating diseases
40
Funding: $355.7M
RapidSOS is an advanced emergency technology company that provides a bridge between mobile phone calls to 911 and legacy 911 PSAP services.
RapidSOS is an advanced emergency technology company that provides a bridge between mobile phone calls to 911 and legacy 911 PSAP services.
41
Funding: $337M
Alaunos Therapeutics develops immunotherapies for cancer treatment using novel TCR-derived T cells. These cell therapies target neoantigens (neoAgs) arising from genomic mutations in solid tumors. The company has developed proprietary, rapid and cost-effective solutions for the delivery of tumor-specific killer T cells. Alaunos' clinical TCR library targets the most common mutations in the KRAS, TP53 and EGFR genes, which are prevalent in gastrointestinal (colon, bile duct, pancreatic), lung and gynecologic (ovarian and endometrial) cancers across a range of different HLA alleles. Company's propriety non-viral Sleeping Beauty transposon/transposase system is used to introduce the TCR gene into the patient's autologous T cells. Alaunos's current pipeline includes clinical trials against lung, colorectal, pancreatic and ovarian cancers.
Alaunos Therapeutics develops immunotherapies for cancer treatment using novel TCR-derived T cells. These cell therapies target neoantigens (neoAgs) arising from genomic mutations in solid tumors. The company has developed proprietary, rapid and cost-effective solutions for the delivery of tumor-specific killer T cells. Alaunos' clinical TCR library targets the most common mutations in the KRAS, TP53 and EGFR genes, which are prevalent in gastrointestinal (colon, bile duct, pancreatic), lung and gynecologic (ovarian and endometrial) cancers across a range of different HLA alleles. Company's propriety non-viral Sleeping Beauty transposon/transposase system is used to introduce the TCR gene into the patient's autologous T cells. Alaunos's current pipeline includes clinical trials against lung, colorectal, pancreatic and ovarian cancers.
42
Funding: $330M
Synchron is developing brain-computer interfaces (BCIs). They use minimally invasive methods compared to earlier BCIs and focus on clinical applications for people with paralysis and amyotrophic lateral sclerosis (for letting them control devices with thought power). It installs its Stentrode implant to the brain with a catheter through blood vessels (without opening the skull). It has fewer electrodes than Neuralink's one and enables the link only in one direction - from the brain to the computer, but it's safer and compatible with existing medical technologies. The first successful human use was in 2019.
Synchron is developing brain-computer interfaces (BCIs). They use minimally invasive methods compared to earlier BCIs and focus on clinical applications for people with paralysis and amyotrophic lateral sclerosis (for letting them control devices with thought power). It installs its Stentrode implant to the brain with a catheter through blood vessels (without opening the skull). It has fewer electrodes than Neuralink's one and enables the link only in one direction - from the brain to the computer, but it's safer and compatible with existing medical technologies. The first successful human use was in 2019.
43
Funding: $325.5M
Headway is building a new mental healthcare system that everyone can access.
Headway is building a new mental healthcare system that everyone can access.
44
Funding: $324.9M
Accelerating the fight against cancer requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform. Flatiron Health gathers and analyzes data on cancer treatments and sells software based on those insights
Accelerating the fight against cancer requires the entire industry to work together. Our products connect community oncologists, academics, hospitals, life science researchers and regulators on a shared technology platform. Flatiron Health gathers and analyzes data on cancer treatments and sells software based on those insights
45
Funding: $320.5M
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.
46
Funding: $317.8M
Emendo Biotherapeutics develops gene editing platform to expand the list of diseases amenable to treatment with gene editing, resulting in a pipeline of hematology and ophthalmology programs.
Emendo Biotherapeutics develops gene editing platform to expand the list of diseases amenable to treatment with gene editing, resulting in a pipeline of hematology and ophthalmology programs.
47
Funding: $315M
Redesign Health helps build, launch and find funding for digital health startups
Redesign Health helps build, launch and find funding for digital health startups
48
Funding: $306.3M
Kindbody provides a full range of health, fertility services, and treatments for women.
Kindbody provides a full range of health, fertility services, and treatments for women.
49
Funding: $304.1M
OWKIN is the AI startup that uses machine learning to augment medical and biology research. Our proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes.
OWKIN is the AI startup that uses machine learning to augment medical and biology research. Our proprietary platform, OWKIN Socrates, uses machine learning technology to integrate biomedical images, genomics and clinical data to discover biomarkers and mechanisms associated with diseases and treatment outcomes.
50
Funding: $298.9M
AI-enabled healthcare data insights company H1 is solving data problems for healthcare and life science companies
AI-enabled healthcare data insights company H1 is solving data problems for healthcare and life science companies
